Global Healthcare

Global Biosensors Market Size is Expected to Grow From USD 21.3 Billion in 2019 to USD 40.5 Billion by 2027, at a CAGR of 15.4%

Press release   •   Jul 10, 2019 06:25 BST

The global biosensors market size is expected to grow from USD 21.3 billion in 2019 to USD 40.5 billion by 2027, at a CAGR of 15.4%. The growth is likely to be driven by continuous technological advancements in biosensors ecosystem, increase in the use of biosensors for nonmedical applications, lucrative growth in POC diagnostics, and rise in demand for glucose monitoring systems.

Key Market Players

F. Hoffman-La Roche Ltd. (Switzerland), Medtronic Inc. (US), LifeScan Inc. (US), Universal Biosensors Inc. (Australia), Abbott Point of Care Inc. (US), DuPont (US), Sysmex Corporation (Japan), Pharmaco-Kinesis Corporation (PKC) (US), ACON Laboratories, Inc. (US), LifeSensors Inc. (US), Bio-Rad laboratories Inc. (US), Biacore (Sweden), Nova Biomedical Corp. (US), and Biosensors International Pte. Ltd. (US) are among the companies operating in the biosensors market.

Medtronic, Inc. (US) is a leading developer and manufacturer of medical devices, therapies, and services used for treating heart, spinal, neurological, vascular, and diabetic conditions. It operates in 4 business segments—Minimally Invasive Therapy Group, Cardiac and Vascular Group, Restorative Therapies Group, and Diabetes Group. The company offers a wide range of products and has operations in North America, APAC, and Europe. To increase production efficiency and gain a competition edge, Medtronic, Inc. adopts mergers and acquisitions as its growth strategy. For instance, in October 2015, Medtronic, Inc. (US) acquired Twelve, Inc. (US), a medical device company that develops transcatheter mitral valve replacement devices. It was acquired by Medtronic’s Coronary & Structural Heart division.

LifeScan Inc. (US) is a subsidiary of Johnson & Johnson, which accounted for a market share of 11%, in 2015. The company offers a comprehensive range of products in the field of medical diabetes. It manufactures and markets blood glucose monitoring solutions for hospitals and consumer use.

The company adopts product launches, agreements, and partnerships as its key growth strategies. For instance, in March 2016, the company signed an agreement with WellDoc Inc. (US) to integrate LifeScan’s OneTouch Verio Flex blood glucose monitoring system and OneTouch Reveal mobile application with WellDoc’s BlueStar diabetes management platform and mobile app. In January 2015, the company launched the OneTouch Verio blood glucose monitoring system that helps people with diabetes to measure their blood glucose level.

Get Sample Copy Of This Report @ https://www.visionresearchreports.com/report/sample/2487

KEY MARKET BENEFITS:

  • The report provides a quantitative analysis of the current market and estimations through 2014-2018, which would enable the stakeholders to capitalize on prevailing market opportunities
  • Extensive analysis of the global apheresis equipment market by product type helps in understanding the types of equipment that are currently used along with the variants that would gain prominence in future
  • Competitive intelligence highlights the business practices followed by leading market players across various geographies
  • Comprehensive analysis of factors that drive and restrict the growth of the global apheresis equipment market is provided
  • SWOT analysis highlights the internal environment of leading companies for effective strategy formulation
  • The apheresis equipment market scenario is comprehensively analysed in accordance to the key regions

KEY MARKET SEGMENTS:

The Global Biosensors Market is segmented as below:

Biosensors Market By Technology

  • Electrochemical Biosensors
  • Optical Sensors
  • Thermal Biosensors
  • Piezoelectric Sensors
  • Others(Field Effect Transistor)

Biosensors Market By Application

  • Medical
  • Food Toxicity Detection
  • Agriculture
  • Industrial Process Control
  • Environmental Monitoring
  • Others (Defense, drug abuse prevention)

Biosensors Market By Product Type

  • Wearable Biosensors
    • Eye wear
    • Wrist Wear
    • Body Wear
    • Foot Wear
    • Neck Wear
    • Others(Biosensor rings)
  • Non Wearable Biosensors

Biosensors Market By Geography

  • North America
  • Europe
  • Asia Pacific
  • LAMEA


Request To Get Complete Report TOC and List Of Figures @ https://www.visionresearchreports.com/biosensors-market-size-share-growth-trends-and-forecast-2017-2026/toc/2487


Table Of Content


Report Content

Chapter 1. Methodology

1.1. Methodology

1.2. Market definitions

1.3. Forecast parameters

1.4. Data sources

1.4.1. Secondary

1.4.1.1. Paid sources

1.4.1.2. Unpaid sources

1.4.2. Primary

Chapter 2. Executive Summary

2.1. Biosensors industry 3600 synopsis, 2014 - 2027

2.1.1. Business trends

2.1.2. Type trends

2.1.2.1. Wearable biosensors

2.1.2.2. Non-wearable biosensors

2.1.2.3. Growth trends in biosensors type

2.1.2.4. Latest type trends

2.1.2.4.1. Chem-Phys patch device

2.1.2.4.2. Wearable imaging

2.1.2.5. Some of the recent launches in wearable biosensors industry

2.1.3. Technology trends

2.1.3.1. Electrochemical biosensors

2.1.3.2. Optical biosensors

2.1.3.3. Thermal biosensors

2.1.3.4. Piezoelectric biosensors

2.1.3.5. Growth trends in biosensors technology

2.1.3.6. Latest technology trends

2.1.3.6.1. Nano biosensors: The future of disease diagnosis

2.1.3.6.2. Application of biosensors in animal healthcare

2.1.3.7. Some of the recent launches in the field of biosensors technology

2.1.3.8. Growth potential analysis for latest biosensors technologies

2.1.3.9. Forecast

2.1.4. Medical application trends

2.1.4.1. Blood glucose testing

2.1.4.2. Cholesterol testing

2.1.4.3. Blood gas analysis

2.1.4.4. Pregnancy testing

2.1.4.5. Drug discovery

2.1.4.6. Infectious disease testing

2.1.4.7. Growth trends in biosensors application

2.1.4.8. Latest medical application trends

2.1.4.8.1. Monitoring glucose in other physiological fluids

2.1.5. End-use trends

2.1.5.1. Point of care testing

2.1.5.2. Home healthcare diagnostics

2.1.5.3. Research laboratories

2.1.5.4. Growth trends in biosensors end-use

2.1.6. Regional trends

2.1.6.1. North America

2.1.6.2. Europe

2.1.6.3. Asia Pacific

2.1.6.4. Latin America

2.1.6.5. Middle East and Africa

2.1.6.6. Growth trends in biosensors industry as per geography

2.1.6.7. Latest trends

2.1.6.7.1. France

2.1.6.7.2. China

2.1.6.7.3. Israel

2.1.6.7.4. UK

2.1.6.7.5. Finland

2.1.6.7.6. India

2.1.6.7.7. Switzerland

Chapter 3. Biosensors Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2014 - 2027

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.1.1. Growing applications of biosensors in the medical field

3.3.1.2. Rising prevalence of diabetes globally

3.3.1.3. High demand for portable biosensors in Asia Pacific and Europe

3.3.1.4. Technological advancements

3.3.2. Industry pitfalls and challenges

3.3.2.1. Stringent regulatory scenario

3.3.2.2. High cost of product development

3.4. Growth potential analysis

3.4.1. By type

3.4.2. By technology

3.4.3. By medical application

3.4.4. By end-use

3.5. Porter’s analysis

3.6. Competitive landscape, 2017

3.6.1. Strategy dashboard

3.7. PESTEL analysis

Chapter 4. Biosensors Market, By Type

4.1. Key segment trends

4.2. Wearable biosensors

4.2.1. Market size, by region, 2014-2027 (USD Million)

4.3. Non-wearable biosensors

4.3.1. Market size, by region, 2014-2027 (USD Million)

Chapter 5. Biosensors Market, By Technology

5.1. Key segment trends

5.2. Electrochemical

5.2.1. Market size, by region, 2014-2027 (USD Million)

5.3. Optical

5.3.1. Market size, by region, 2014-2027 (USD Million)

5.4. Thermal

5.4.1. Market size, by region, 2014-2027 (USD Million)

5.5. Piezoelectric

5.5.1. Market size, by region, 2014-2027 (USD Million)

5.6. Others

5.6.1. Market size, by region, 2014-2027 (USD Million)

Chapter 6. Biosensors Market, By Medical Application

6.1. Key segment trends

6.2. Blood glucose testing

6.2.1. Market size, by region, 2014-2027 (USD Million)

6.3. Cholesterol testing

6.3.1. Market size, by region, 2014-2027 (USD Million)

6.4. Blood gas analysis

6.4.1. Market size, by region, 2014-2027 (USD Million)

6.5. Pregnancy testing

6.5.1. Market size, by region, 2014-2027 (USD Million)

6.6. Drug discovery

6.6.1. Market size, by region, 2014-2027 (USD Million)

6.7. Infectious disease testing

6.7.1. Market size, by region, 2014-2027 (USD Million)

6.8. Others

6.8.1. Market size, by region, 2014-2027 (USD Million)

Chapter 7. Biosensors Market, By End-use

7.1. Key segment trends

7.2. Point of care testing

7.2.1. Market size, by region, 2014-2027 (USD Million)

7.3. Home healthcare diagnostics

7.3.1. Market size, by region, 2014-2027 (USD Million)

7.4. Research laboratories

7.4.1. Market size, by region, 2014-2027 (USD Million)

7.5. Others

7.5.1. Market size, by region, 2014-2027 (USD Million)

Chapter 8. Biosensors Market, By Region

8.1. Key regional market

8.2. North America

8.2.1. Market size, by country, 2014 – 2027 (USD Million)

8.2.2. Market size, by type, 2014 – 2027 (USD Million)

8.2.3. Market size, by technology, 2014 – 2027 (USD Million)

8.2.4. Market size, by medical application, 2014 – 2027 (USD Million)

8.2.5. Market size, by end-use, 2014-2027 (USD Million)

8.2.6. U.S.

8.2.6.1. Market size, by type, 2014 - 2027 (USD Million)

8.2.6.2. Market size, by technology, 2014 - 2027 (USD Million)

8.2.6.3. Market size, by medical application, 2014 - 2027 (USD Million)

8.2.6.4. Market size, by end-use, 2014-2027 (USD Million)

8.2.7. Canada

8.2.7.1. Market size, by type, 2014 – 2027 (USD Million)

8.2.7.2. Market size, by technology, 2014 - 2027 (USD Million)

8.2.7.3. Market size, by medical application, 2014 - 2027 (USD Million)

8.2.7.4. Market size, by end-use, 2014-2027 (USD Million)

8.3. Europe

8.3.1. Market size, by country, 2014 - 2027 (USD Million)

8.3.2. Market size, by type, 2014 - 2027 (USD Million)

8.3.3. Market size, by technology, 2014 - 2027 (USD Million)

8.3.4. Market size, by medical application, 2014 - 2027 (USD Million)

8.3.5. Market size, by end-use, 2014-2027 (USD Million)

8.3.6. Germany

8.3.6.1. Market size, by type, 2014 – 2027 (USD Million)

8.3.6.2. Market size, by technology, 2014 - 2027 (USD Million)

8.3.6.3. Market size, by medical application, 2014 - 2027 (USD Million)

8.3.6.4. Market size, by end-use, 2014-2027 (USD Million)

8.3.7. UK

8.3.7.1. Market size, by type, 2014 - 2027 (USD Million)

8.3.7.2. Market size, by technology, 2014 - 2027 (USD Million)

8.3.7.3. Market size, by medical application, 2014 - 2027 (USD Million)

8.3.7.4. Market size, by end-use, 2014-2027 (USD Million)

8.3.8. France

8.3.8.1. Market size, by type, 2014 - 2027 (USD Million)

8.3.8.2. Market size, by technology, 2014 - 2027 (USD Million)

8.3.8.3. Market size, by medical application, 2014-2027 (USD Million)

8.3.8.4. Market size, by end-use, 2014-2027 (USD Million)

8.3.9. Italy

8.3.9.1. Market size, by type, 2014 - 2027 (USD Million)

8.3.9.2. Market size, by technology, 2014 - 2027 (USD Million)

8.3.9.3. Market size, by medical application, 2014-2027 (USD Million)

8.3.9.4. Market size, by end-use, 2014-2027 (USD Million)

8.3.10. Spain

8.3.10.1. Market size, by type, 2014 - 2027 (USD Million)

8.3.10.2. Market size, by technology, 2014 - 2027 (USD Million)

8.3.10.3. Market size, by medical application, 2014-2027 (USD Million)

8.3.10.4. Market size, by end-use, 2014-2027 (USD Million)

8.3.11. Russia

8.3.11.1. Market size, by type, 2014 - 2027 (USD Million)

8.3.11.2. Market size, by technology, 2014 - 2027 (USD Million)

8.3.11.3. Market size, by medical application, 2014-2027 (USD Million)

8.3.11.4. Market size, by end-use, 2014-2027 (USD Million)

8.3.12. Switzerland

8.3.12.1. Market size, by type, 2014 - 2027 (USD Million)

8.3.12.2. Market size, by technology, 2014 - 2027 (USD Million)

8.3.12.3. Market size, by medical application, 2014-2027 (USD Million)

8.3.12.4. Market size, by end-use, 2014-2027 (USD Million)

8.4. Asia Pacific

8.4.1. Market size, by country, 2014 - 2027 (USD Million)

8.4.2. Market size, by type, 2014 - 2027 (USD Million)

8.4.3. Market size, by technology, 2014 - 2027 (USD Million)

8.4.4. Market size, by medical application, 2014-2027 (USD Million)

8.4.5. Market size, by end-use, 2014-2027 (USD Million)

8.4.6. China

8.4.6.1. Market size, by type, 2014 - 2027 (USD Million)

8.4.6.2. Market size, by technology, 2014 - 2027 (USD Million)

8.4.6.3. Market size, by medical application, 2014-2027 (USD Million)

8.4.6.4. Market size, by end-use, 2014-2027 (USD Million)

8.4.7. India

8.4.7.1. Market size, by type, 2014 - 2027 (USD Million)

8.4.7.2. Market size, by technology, 2014 - 2027 (USD Million)

8.4.7.3. Market size, by medical application, 2014-2027 (USD Million)

8.4.7.4. Market size, by end-use, 2014-2027 (USD Million)

8.4.8. Japan

8.4.8.1. Market size, by type, 2014 - 2027 (USD Million)

8.4.8.2. Market size, by technology, 2014 - 2027 (USD Million)

8.4.8.3. Market size, by medical application, 2014-2027 (USD Million)

8.4.8.4. Market size, by end-use, 2014-2027 (USD Million)

8.5. Latin America

8.5.1. Market size, by country, 2014 - 2027 (USD Million)

8.5.2. Market size, by type, 2014 - 2027 (USD Million)

8.5.3. Market size, by technology, 2014 - 2027 (USD Million)

8.5.4. Market size, by medical application, 2014-2027 (USD Million)

8.5.5. Market size, by end-use, 2014-2027 (USD Million)

8.5.6. Brazil

8.5.6.1. Market size, by type, 2014 - 2027 (USD Million)

8.5.6.2. Market size, by technology, 2014 - 2027 (USD Million)

8.5.6.3. Market size, by medical application, 2014-2027 (USD Million)

8.5.6.4. Market size, by end-use, 2014-2027 (USD Million)

8.5.7. Mexico

8.5.7.1. Market size, by type, 2014 - 2027 (USD Million)

8.5.7.2. Market size, by technology, 2014 - 2027 (USD Million)

8.5.7.3. Market size, by medical application, 2014-2027 (USD Million)

8.5.7.4. Market size, by end-use, 2014-2027 (USD Million)

8.6. MEA

8.6.1. Market size, by country, 2014 - 2027 (USD Million)

8.6.2. Market size, by type, 2014 - 2027 (USD Million)

8.6.3. Market size, by technology, 2014 - 2027 (USD Million)

8.6.4. Market size, by medical application, 2014-2027 (USD Million)

8.6.5. Market size, by end-use, 2014-2027 (USD Million)

8.6.6. South Africa

8.6.6.1. Market size, by type, 2014 - 2027 (USD Million)

8.6.6.2. Market size, by technology, 2014 - 2027 (USD Million)

8.6.6.3. Market size, by medical application, 2014-2027 (USD Million)

8.6.6.4. Market size, by end-use, 2014-2027 (USD Million)

8.6.7. Saudi Arabia

8.6.7.1. Market size, by type, 2014 - 2027 (USD Million)

8.6.7.2. Market size, by technology, 2014 - 2027 (USD Million)

8.6.7.3. Market size, by medical application, 2014-2027 (USD Million)

8.6.7.4. Market size, by end-use, 2014-2027 (USD Million)

Chapter 9. Company Profiles

9.1. Abbott Laboratories

9.1.1. Business overview

9.1.2. Financial data

9.1.3. Product landscape

9.1.4. Strategic outlook

9.1.5. SWOT analysis

9.2. Bio-Rad International

9.2.1. Business overview

9.2.2. Financial data

9.2.3. Product landscape

9.2.4. Strategic outlook

9.2.5. SWOT analysis

9.3. Biosensors International

9.3.1. Business overview

9.3.2. Financial data

9.3.3. Product landscape

9.3.4. Strategic outlook

9.3.5. SWOT analysis

9.4. DowDuPont Inc.

9.4.1. Business overview

9.4.2. Financial data

9.4.3. Product landscape

9.4.4. Strategic outlook

9.4.5. SWOT analysis

9.5. Ercon, Inc.

9.5.1. Business overview

9.5.2. Financial data

9.5.3. Product landscape

9.5.4. Strategic outlook

9.5.5. SWOT analysis

9.6. Gwent Group

9.6.1. Business overview

9.6.2. Financial data

9.6.3. Product landscape

9.6.4. Strategic outlook

9.6.5. SWOT analysis

9.7. Johnson & Johnson

9.7.1. Business overview

9.7.2. Financial data

9.7.3. Product landscape

9.7.4. Strategic outlook

9.7.5. SWOT analysis

9.8. Molecular Devices Corp.

9.8.1. Business overview

9.8.2. Financial data

9.8.3. Product landscape

9.8.4. Strategic outlook

9.8.5. SWOT analysis

9.9. Pinnacle Technology

9.9.1. Business overview

9.9.2. Product landscape

9.9.3. Strategic outlook

9.9.4. SWOT analysis

9.10. QTL Biosystems

9.10.1. Business overview

9.10.2. Financial data

9.10.3. Product landscape

9.10.4. Strategic outlook

9.10.5. SWOT analysis

9.11. Roche Diagnostics

9.11.1. Business overview

9.11.2. Financial data

9.11.3. Product landscape

9.11.4. Strategic outlook

9.11.5. SWOT analysis

9.12. SDIX, LLC

9.12.1. Business overview

9.12.2. Financial data

9.12.3. Product landscape

9.12.4. Strategic outlook

9.12.5. SWOT analysis

9.13. Siemens Healthineers

9.13.1. Business overview

9.13.2. Financial data

9.13.3. Product landscape

9.13.4. Strategic outlook

9.13.5. SWOT analysis

9.14. TE Connectivity Corporation

9.14.1. Business overview

9.14.2. Financial data

9.14.3. Product landscape

9.14.4. Strategic outlook

9.14.5. SWOT analysis

9.15. Thermo-Fisher Scientific

9.15.1. Business overview

9.15.2. Financial data

9.15.3. Product landscape

9.15.4. Strategic outlook

9.15.5. SWOT analysis

Request To Buy This Premium Report @ https://www.visionresearchreports.com/report/cart/2487

About Us

Vision Research Reports is unquestionably an expert in providing research reports on a diverse number of subjects including Alternative and Green Energy, Chemical, Energy, Glass, Machinery, Manufacturing, and Pharmaceuticals and Materials. We cater to distinguished MNCs, private equity firms, SMEs and Chinese companies pertaining to their market research data requirements.

Contact Us

Sai Krupa

Office no.1, shivneri nagar,

kondhwa Khurd,

Pune 411048

Website:- www.visionresearchreports.com

E:- sales@visionresearchreports.com

Follow Us:- www.linkedin.com/company/vision-research-reports